{
  "attach_pages": "5",
  "attach_size": "545",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201807091164667950_1.pdf?1531316169000.pdf",
  "company_code": "10000082",
  "eitime": "2018-07-09 14:52:46",
  "extend": {},
  "info_code": "AP201807091164667950",
  "language": "0",
  "notice_date": "2018-07-09 00:00:00",
  "notice_title": "医药高增长和地产收入确认是业绩超预期原因",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "A",
  "researcher": "李敬雷",
  "security": [
    {
      "market_uni": "0",
      "publish_relation": [
        {
          "originalCode": "1044",
          "publishName": "生物制品"
        }
      ],
      "short_name": "长春高新",
      "short_name_ch": "长春高新",
      "short_name_cht": "長春高新",
      "short_name_en": "CCHN",
      "stock": "000661"
    }
  ],
  "short_name": "长春高新",
  "source_sample_name": "国金证券",
  "star": "5"
}